300 related articles for article (PubMed ID: 17932104)
1. A repressive role for prohibitin in estrogen signaling.
He B; Feng Q; Mukherjee A; Lonard DM; DeMayo FJ; Katzenellenbogen BS; Lydon JP; O'Malley BW
Mol Endocrinol; 2008 Feb; 22(2):344-60. PubMed ID: 17932104
[TBL] [Abstract][Full Text] [Related]
2. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
3. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
4. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR
Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272
[TBL] [Abstract][Full Text] [Related]
6. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
Kim JW; Akiyama M; Park JH; Lin ML; Shimo A; Ueki T; Daigo Y; Tsunoda T; Nishidate T; Nakamura Y; Katagiri T
Cancer Sci; 2009 Aug; 100(8):1468-78. PubMed ID: 19496786
[TBL] [Abstract][Full Text] [Related]
7. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
Gamble SC; Chotai D; Odontiadis M; Dart DA; Brooke GN; Powell SM; Reebye V; Varela-Carver A; Kawano Y; Waxman J; Bevan CL
Oncogene; 2007 Mar; 26(12):1757-68. PubMed ID: 16964284
[TBL] [Abstract][Full Text] [Related]
8. Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor.
Karmakar S; Foster EA; Smith CL
Int J Cancer; 2009 Apr; 124(8):1841-51. PubMed ID: 19117054
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
10. Truncated estrogen receptor product-1 stimulates estrogen receptor alpha transcriptional activity by titration of repressor proteins.
Lin VY; Resnick EM; Shupnik MA
J Biol Chem; 2003 Oct; 278(40):38125-31. PubMed ID: 12878603
[TBL] [Abstract][Full Text] [Related]
11. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-regulated prohibitin is required for mouse uterine development and adult function.
He B; Kim TH; Kommagani R; Feng Q; Lanz RB; Jeong JW; DeMayo FJ; Katzenellenbogen BS; Lydon JP; O'Malley BW
Endocrinology; 2011 Mar; 152(3):1047-56. PubMed ID: 21209023
[TBL] [Abstract][Full Text] [Related]
13. Novel role for PINX1 as a coregulator of nuclear hormone receptors.
Noriega-Reyes MY; Rivas-Torres MA; Oñate-Ocaña LF; Vallés AJ; Baranda-Avila N; Langley E
Mol Cell Endocrinol; 2015 Oct; 414():9-18. PubMed ID: 26187699
[TBL] [Abstract][Full Text] [Related]
14. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
[TBL] [Abstract][Full Text] [Related]
15. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human estrogen receptor alpha-mediated gene transactivation in Saccharomyces cerevisiae by human coactivator and corepressor proteins.
Bitter GA
J Steroid Biochem Mol Biol; 2007 Feb; 103(2):189-95. PubMed ID: 17194583
[TBL] [Abstract][Full Text] [Related]
18. G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.
Cheng X; Kao HY
J Biol Chem; 2009 Dec; 284(52):36395-36404. PubMed ID: 19858209
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
Monroe DG; Secreto FJ; Subramaniam M; Getz BJ; Khosla S; Spelsberg TC
Mol Endocrinol; 2005 Jun; 19(6):1555-68. PubMed ID: 15802376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]